Most gene mutations that lead to lung cancer happen because of things you’ve been exposed to. Tobacco is the most common cause of genetic changes to lung cells, but it isn’t the only one.
The U.S. Food and Drug Administration has declined to approve an injectable version of Johnson & Johnson's drug Rybrevant for ...
Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations ... the most common type of lung cancer.
An FDA-approved drug used to treat multiple myeloma and lymphoma also shrank tumors in non-small cell lung cancer with KRAS ...
An FDA-approved drug used to treat multiple myeloma and lymphoma also shrank tumors in non-small cell lung cancer (NSCLC) ...
PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit looks back on the progress made toward better understanding and ...
Sabari, MD, which focused on the first-line approval of amivantamab (Ami; Rybrevant; Johnson & Johnson) plus lazertinib ...
Rising lung cancer rates in Tamil Nadu, especially among non-smokers and women, call for stricter tobacco laws and pollution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback